Dr. Bruce Burlington is an independent consultant on pharmaceutical product development and regulatory affairs. He was EVP of Regulatory Affairs, Human Safety, and Quality at Wyeth. Before joining Wyeth in 1999, Dr. Burlington had been at FDA since 1981, as director of CDRH, medical deputy director of CDRH, and head of Biologics IND at CBER.